Search Immortality Topics:

Page 20«..10..19202122..3040..»

Category Archives: Pharmacogenomics

Session 6: Closing remarks – Video




Session 6: Closing remarks Session 6: Pharmacogenomics in the global landscape: Pharmacogenetics and Ethnicity Speaker: Tomas Salmonson, Chairman of the Committee for Medicinal Products for Human Use, EMA Workshop on Pharmacogenomics: from science to clinical care (8 October 2012)From:emainfoViews:0 0ratingsTime:04:42More inScience Technology Continue reading

Source Link(s) Are Here

Session 6: Closing remarks - Video

Posted in Pharmacogenomics | Comments Off on Session 6: Closing remarks – Video

Session 5: Panel discussion – Video




Session 5: Panel discussion Session 5: Pharmacogenomics: impact and needs from health care view point to facilitate patients' access Panel discussion Workshop on Pharmacogenomics: from science to clinical care (8 October 2012)From:emainfoViews:0 0ratingsTime:20:56More inScience Technology Continue reading

Source Link(s) Are Here

Session 5: Panel discussion - Video

Posted in Pharmacogenomics | Comments Off on Session 5: Panel discussion – Video

Session 6: Introduction – Video




Session 6: Introduction Session 6: Pharmacogenomics in the global landscape: Pharmacogenetics and Ethnicity Speaker: Stephen Spielberg, FDA, USA Workshop on Pharmacogenomics: from science to clinical care (8 October 2012)From:emainfoViews:0 0ratingsTime:08:22More inScience Technology Continue reading

Source Link(s) Are Here

Session 6: Introduction - Video

Posted in Pharmacogenomics | Comments Off on Session 6: Introduction – Video

Session 3: Post-approval pharmacogenomics: impact on Risk Management Plans and Information – Video




Session 3: Post-approval pharmacogenomics: impact on Risk Management Plans and Information Speaker: Isabelle Moulon, Head of Sector for Medical information, EMA Workshop on Pharmacogenomics: from science to clinical care (8 October 2012)From:emainfoViews:0 0ratingsTime:10:23More inScience Technology Continue reading

Source Link(s) Are Here

Session 3: Post-approval pharmacogenomics: impact on Risk Management Plans and Information - Video

Posted in Pharmacogenomics | Comments Off on Session 3: Post-approval pharmacogenomics: impact on Risk Management Plans and Information – Video

Session 5: IVDD revision – Video




Session 5: IVDD revision Session 5: Pharmacogenomics: impact and needs from health care view point to facilitate patients' access Speaker: Fabio Faraulo, European Commission, Belgium Workshop on Pharmacogenomics: from science to clinical care (8 October 2012)From:emainfoViews:0 0ratingsTime:20:09More inScience Technology Continue reading

Source Link(s) Are Here

Session 5: IVDD revision - Video

Posted in Pharmacogenomics | Comments Off on Session 5: IVDD revision – Video

Key themes from the consultation and next steps – Video




Key themes from the consultation and next steps Session 1: Pharmacogenomics: regulatory and methodological implications in early clinical development Speaker: Priya Bahri, European Medicines Agency Workshop on Pharmacogenomics: from science to clinical care (8 October 2012)From:emainfoViews:0 0ratingsTime:38:13More inScience Technology Continue reading

Source Link(s) Are Here

Key themes from the consultation and next steps - Video

Posted in Pharmacogenomics | Comments Off on Key themes from the consultation and next steps – Video